Analystreport

Mesoblast limited (NASDAQ: MESO) had its price target lowered by analysts at Maxim Group from $22.00 to $18.00.

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com